Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2008
12/18/2008US20080312319 Modulation of Bacterial Quorum Sensing with Synthetic Ligands
12/18/2008US20080312285 Substituted Indazoles as Inhibitors of Phosphodiesterase Type-Iv
12/18/2008US20080312259 SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312255 Piperdine compounds and uses thereof-911
12/18/2008US20080312245 Methods and compositions for treating acne and other infectious diseases
12/18/2008US20080312238 4-Arylazo-3,5-Diamino-Pyrazole Compounds and Use Thereof
12/18/2008US20080312222 4-Benzyledene-Piperidin Derivatives
12/18/2008US20080312219 Biologically active methylene blue derivatives
12/18/2008US20080312211 Antibacterial Pyrrolopyridines, Pyrrolopyrimidines and Pyrroloazepines-154
12/18/2008US20080312204 Soluble forms of amoxicillin and treatment of animals
12/18/2008US20080312203 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections
12/18/2008US20080312199 Treatments of therapy resistant diseases and drug combinations for treating the same
12/18/2008US20080312173 Treatment of HSV-related pathologies using plasmids that make ssDNA
12/18/2008US20080312167 4'' Amino Linked Macrolides Useful for the Treatment of Microbial Infections
12/18/2008US20080312160 Method of treating enteritis, intestinal damage, and diarrhea from c. difficile with an a2a adenosine receptor agonist
12/18/2008US20080312159 Dendrimeric peptides, pharmaceutical compositions and methods of using the same
12/18/2008US20080312158 Semaphorin Gene Family
12/18/2008US20080312144 Peptides for the Treatment of Herpes Virus Infections
12/18/2008US20080312140 Compositions and Methods for Preventing or Treating Hiv Infection
12/18/2008US20080312137 Fed Batch Culture Methods for Streptococci
12/18/2008US20080311624 Chimeric immunogens
12/18/2008US20080311231 Broad Spectrum Non-Traditional Preservative System
12/18/2008US20080311188 Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol
12/18/2008US20080311158 Hepatitis C Virus Replication System
12/18/2008US20080311157 Pharmaceutical Compound Capable of Induce Immune Protective Response Against Dengue Virus Having the Capsid Protein of the Dengue Virus
12/18/2008US20080311156 Vaccines
12/18/2008US20080311155 Strain-Independent Amplification of Pathogens and Vaccines Thereto
12/18/2008US20080311154 Cold-adapted equine influenza viruses
12/18/2008US20080311153 prepared by mating isolated strains; for prevention of seasonal and sudden outbreaks
12/18/2008US20080311151 Vaccine For Periodontal Disease
12/18/2008US20080311150 Novel sequences encoding hepatitis C virus glycoproteins
12/18/2008US20080311149 DNA-transfection system for the generation of infectious influenza virus
12/18/2008US20080311148 DNA-transfection system for the generation of infectious influenza virus
12/18/2008US20080311147 Rhabdoviral N-Fusion Proteins as Carrier for Foreign Antigens
12/18/2008US20080311144 Mutant forms of cholera holotoxin as an adjuvant
12/18/2008US20080311143 Porcine reproductive respiratory syndrome virus (PRRSV); replicons
12/18/2008US20080311142 Cancer vaccines and vaccination methods
12/18/2008US20080311141 Cancer vaccines and vaccination methods
12/18/2008US20080311130 Integrin Alpha L I Domain Mutants with Increased Binding Affinity
12/18/2008US20080311129 Adherence inhibitor directed to and method of making and using
12/18/2008US20080311126 Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer
12/18/2008US20080311125 Scytovirin Domain 1 Related Polypeptides
12/18/2008US20080311112 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
12/18/2008US20080311110 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease
12/18/2008US20080311108 Polypeptides
12/18/2008US20080311106 Product Comprising a C4bp Core Protein and a monomeric Antigen, and Its Use
12/18/2008US20080311080 Bifidobacterium in the treatment of inflammatory disease
12/18/2008US20080311079 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
12/18/2008US20080311077 Antiviral Compounds
12/18/2008US20080311076 Morpholinylanilinoquinazoline Derivatives For Use As Antiviral Agents
12/18/2008US20080311075 Hepatitis C Virus Inhibitors
12/18/2008US20080311056 treating and preventing tooth decay; remove selectively cariogenic bacteria or to decrease the number of cariogenic bacteria inside oral cavity, and may exert preventive effect against tooth caries
12/18/2008US20080311042 Loop-Variant Pdz Domains as Biotherapeutics, Diagnostics and Research Reagents
12/18/2008US20080311034 Anti-Tissue Factor Antibodies and Compositions with Enhanced Effector Function
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2694871A1 Chemical compounds
12/18/2008CA2690643A1 Oligonucleotides for modulation of target rna activity
12/18/2008CA2690267A1 Small cationic antimicrobial peptides
12/18/2008CA2689212A1 Terpenes with antifungal activity against malassezia yeasts
12/18/2008CA2689102A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/18/2008CA2687172A1 Anti-norovirus agent and composition containing the same
12/18/2008CA2685066A1 Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis
12/18/2008CA2683701A1 Use of isoosmotic seawater-based ionic solutions for manufacturing medical devices for the prevention of complications of the common cold or of the flu syndrome
12/18/2008CA2681454A1 Raccoon poxvirus expressing rabies glycoproteins
12/18/2008CA2667788A1 Staphylococcus aureus specific anti-infectives
12/17/2008EP2003198A2 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza
12/17/2008EP2003140A2 Galactose derivative, drug carrier and medicinal composition
12/17/2008EP2003130A2 Novel pyridine derivative having anti-helicobacter pylori activity
12/17/2008EP2003120A1 Azapeptide derivatives as HIV protease inhibitors
12/17/2008EP2001907A2 Methods and compositions for antagonism of rage
12/17/2008EP2001887A1 Pyrrolo-quinoxalinone derivatives as antibacterials
12/17/2008EP2001862A2 Malate salts, and polymorphs of (3s,5s)-7-ý3-amino-5-methyl-piperidinyl¨-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
12/17/2008EP2001840A1 Associations of xanthogenates and cyclodextrins, and their use
12/17/2008EP2001466A2 Formulations and methods for vascular permeability-related diseases or conditions
12/17/2008EP2001465A1 Antibiotic compositions of modified release and process of production thereof
12/17/2008EP2001440A1 Biguanide-containing liposomes
12/17/2008EP1773763B1 Lysine based compounds
12/17/2008EP1763342B1 Sphingolipids against pathological processes in lipid rafts
12/17/2008EP1753736B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/17/2008EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity
12/17/2008EP1503772B1 Soluble composition containing sporopollenin and the use thereof
12/17/2008EP1465914B1 Triterpene quaternary salts as biologically active surfactants
12/17/2008EP1448186B1 Medicament for the treatment of viral skin and tumour diseases
12/17/2008EP1395271B1 Herbal compositions for the treatment of mucosal lesions
12/17/2008EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
12/17/2008EP1077943B1 Heterocyclic inhibitors of p38
12/17/2008CN101326178A Piperazine derivatives useful as CCR5 antagonists
12/17/2008CN101326170A Novel macrolide compounds with antibiotic and antneoplastic properties
12/17/2008CN101325953A 4-heteroaryl-pyrimidine derivatives and use thereof as protein kinase inhibitors
12/17/2008CN101323649A Method for extracting mushroom polysaccharide by using ultra-high pressure
12/17/2008CN101323648A Extraction method and and purification method of Sanghuang mushroom polysaccharide
12/17/2008CN101323635A Panax notoginseng saponins ST-4, and medicinal composition, preparation and use thereof
12/17/2008CN101323623A Novel fourth generation cephalosporin, preparation and use thereof
12/17/2008CN101323616A Carbpenem derivates containing sulfhydryl thiazole
12/17/2008CN101323615A Pennem derivates containing formamide heterocycle sulfonic acid amide sulfhydryl pyrrolidine
12/17/2008CN101323601A Triazole derivatives useful in therapy
12/17/2008CN101323600A Triadimefon and triadimenol compounds having antimicrobial activity, salts, synthetic methods and uses thereof
12/17/2008CN101323599A Chemical synthesis method for 2-formylcyanoacetylhydrazone-quinoxaline-1,4-dioxide
12/17/2008CN101323594A Benzyl chloride tertiary amine double azole antimicrobial compounds, preparation and medical use thereof
12/17/2008CN101322847A Anti-hepatitis b virus gene medicament based on siRNA pool interference and mediated by complex carrier
1 ... 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 ... 1798